archyworldys

Human blood; Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera (antibody sera), other fractions… in Sweden | OEC

Resume: on October 2021 Human blood; Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera (sera containing antibodies), other blood fractions and modified immunological products, including those obtained by biotechnological processes; vaccines, in Sweden exports accounted for up to SEK2.04MM and imports represented up to SEK1.31MM, resulting in a positive trade balance of SEK731M. Between October 2020 and October 2021 the exports of Sweden’s Human blood; Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera (sera containing antibodies), other blood fractions and modified immunological products, including those obtained by biotechnological processes; vaccines, had an increase SEK456M ( 28.9% ) from SEK1.58MM to SEK2.04MM, while imports had an increase of SEK49.5M ( 3.95% ) from SEK1.26MM to SEK1.31MM.

Destinations: On October 2021 Human blood; Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera (sera containing antibodies), other blood fractions and modified immunological products, including those obtained by biotechnological processes; vaccines, exported mainly to Germany (SEK721M), the United States (SEK285M), Singapore (SEK163M), Norway (SEK130M), and the Netherlands (SEK112M), and imported mainly from the United States (SEK360M), Germany (SEK329M), the Netherlands ( SEK125M), Italy (SEK76.8M), and Switzerland (SEK60M).

Growth: On October 2021, the increase in Human Blood; Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera (sera containing antibodies), other blood fractions and modified immunological products, including those obtained by biotechnological processes; vaccines, in year-on-year exports are mainly explained by an increase in exports to the United States (SEK126M or 72.5%), Germany (SEK67.7M or 11.5%), and the Netherlands (SEK52.1M or 66.7%) . In October 2021, the increase in Human Blood; Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera (sera containing antibodies), other blood fractions and modified immunological products, including those obtained by biotechnological processes; vaccines, YoY imports were mainly explained by an increase in imports from the United States (SEK140M or 45.7%), Poland (SEK17.3M or 67.2%), and Norway (SEK8M or 88.9k%).

Read also  Michael Schumacher: Jean Todt confides in his health

Trending